Signet Financial Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-61	Closed	-$5K	–	461
2021 Q4	$5K	Buy	+61	New	+$5K	﹤0.01%	1159
2018 Q2	–	Sell	-210	Closed	-$10K	–	962
2018 Q1	$10K	Buy	+210	New	+$10K	﹤0.01%	574